2005
DOI: 10.1038/sj.ejcn.1602351
|View full text |Cite
|
Sign up to set email alerts
|

Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects

Abstract: Objective: To investigate the effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma plasma total homocysteine (tHcy) concentrations in young Japanese male subjects. Design: In a double blind, randomized controlled trial. Intervention: Subjects were randomly assigned to one of four groups and received a placebo (control group), 800 mg/day folic acid (FA group), 8.4 mg/day riboflavin (R group), or both (FAR group) for 2 weeks. Setting: Tokyo, Japan. Subjects: In total, 32 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
13
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 43 publications
2
13
0
Order By: Relevance
“…The increase, 23.0 ± 30.6 nmol/L (mean ± SD), in the concentration of serum folate and a decrease, 0.7 ± 1.4 lmol/L (mean ± SD), in the concentration of p-tHcy after folic acid supplementation, 0.8 mg/day, for 2 weeks, are similar to the findings, in healthy subjects, reported previously, increase in serum folate 18.0 ± 1.5 nmol/L (mean ± SD) and a decrease in p-tHcy 0.9 ± 0.4 lmol/L (mean ± SD) (Araki et al 2006). It has also been demonstrated that folic acid dose, 0.8 mg/day given to healthy subjects, for 12 weeks, increased the concentration of serum folate from 12.9 ± 3.6 to 53.4 ± 28.3 nmol/L (mean ± SD) and reduced the concentration of p-tHcy from 11.5 ± 2.8 to 9.6 ± 2.2 lmol/(mean ± SD) (change about 25 %) (Van Oort et al 2003).…”
Section: Discussionsupporting
confidence: 77%
“…The increase, 23.0 ± 30.6 nmol/L (mean ± SD), in the concentration of serum folate and a decrease, 0.7 ± 1.4 lmol/L (mean ± SD), in the concentration of p-tHcy after folic acid supplementation, 0.8 mg/day, for 2 weeks, are similar to the findings, in healthy subjects, reported previously, increase in serum folate 18.0 ± 1.5 nmol/L (mean ± SD) and a decrease in p-tHcy 0.9 ± 0.4 lmol/L (mean ± SD) (Araki et al 2006). It has also been demonstrated that folic acid dose, 0.8 mg/day given to healthy subjects, for 12 weeks, increased the concentration of serum folate from 12.9 ± 3.6 to 53.4 ± 28.3 nmol/L (mean ± SD) and reduced the concentration of p-tHcy from 11.5 ± 2.8 to 9.6 ± 2.2 lmol/(mean ± SD) (change about 25 %) (Van Oort et al 2003).…”
Section: Discussionsupporting
confidence: 77%
“…It has been proposed that it acts jointly with folate to lower plasma homocysteine levels. One Japanese study reported that low riboflavin blunted the effect of folic acid, which resulted in a diminished reduction of total homocysteine (33). Conversely, high intake of folic acid supplements was observed to exacerbate a tendency toward riboflavin deficiency (34).…”
Section: Discussionmentioning
confidence: 99%
“…Secondly, we did not measure nutritional status, that is, serum concentrations of folate and vitamins B 12 , which could affect homocysteine metabolism [38]. Previous studies described that supplementation with folic acid increased the serum and red blood cell folate concentrations and decreased the plasma tHcy concentrations in healthy young Japanese male subjects [39]. Thus, it remains uncertain whether nutritional status could affect the presence of WML in RA patients.…”
Section: Discussionmentioning
confidence: 98%